MedTrace Logo

Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy

NCT04638556 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-11-30

No results posted yet for this study

Summary

This project intends to use high-throughput sequencing, molecular biology and bioinformatics technology to clarify the role of target lncrnas in the inflammatory response of DPN, to explore the correlation between target lncrnas and DPN pathogenesis, and to clarify the feasibility of target lncrnas as a marker of DPN cycle.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DIAGNOSTIC_TEST

lncRNA detection

The lncRNAs in the plasma of three groups of patients will be tested.

Sponsors & Collaborators

  • Shanghai Municipal Commission of Health and Family Planning

    collaborator OTHER

  • Jinshan Hospital Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-03
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638556 on ClinicalTrials.gov